首页 > 市场调查报告书 > 製药

神经疾病

市场调查报告书

商品编码

1555527

认知诊断市场，按诊断、按指示、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Cognitive Diagnostics Market, By Diagnosis, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年08月04日 | 出版商:

AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告要点

2023年认知诊断市场规模为53.9021亿美元，2024年至2032年复合年增长率为27.90%。

认知诊断市场-市场动态

全球老年人口的成长和认知障碍盛行率的增加预计将推动市场的成长

全球人口格局正经历快速老化趋势，老年人口数量显着增加。这种人口结构的变化使老年人认知障碍的风险升高，包括阿兹海默症和各种形式的失智症。世界卫生组织预计，到 2030 年，全球六分之一的人将年龄在 60 岁或以上。因此，60岁及以上人口预计将从2020年的10亿增加到14亿。认识的提高和诊断方法的进步有助于提高认知障碍的识别率。随着诊断技术的发展，更多的病例在早期阶段被识别和诊断——此外，持续的技术创新和医疗基础设施的扩展为市场成长提供了重大机会。然而，标准化的缺乏可能会对市场的扩张带来挑战。

认知诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 27.90% 左右的复合年增长率成长

按地区划分，北美是 2023 年的主要收入来源

认知诊断市场区隔分析：

全球认知诊断市场根据诊断、适应症、最终用户和地区进行细分。

根据诊断，市场分为八个不同的类别：脑部影像测试、实验室测试、精神状态测试、快速家庭筛检测试、神经心理测试、脑电图(EEG)、认知功能和行为测试以及神经精神问卷调查(NPI-问）。这些诊断类别中的每一个对于在认知健康领域提供彻底的评估和提高患者的治疗效果至关重要。

根据适应症，市场分为两类：阿兹海默症、失智症和其他神经系统疾病。每个类别都包括用于评估和治疗这些病症的不同诊断工具和方法。

根据最终用户，市场分为两类：医院、神经科诊所、復健中心、学术和研究机构、家庭护理等。每个最终用户组都采用根据其特定要求和环境量身定制的不同诊断工具和技术。

认知诊断市场-地理洞察

市场地理分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲。出于商业目的，这些区域按国家进一步细分。由于对评估认知表现的诊断工具和技术的需求不断增长，北美引领了市场成长。该地区是技术进步的先驱，特别是在人工智慧 (AI) 和机器学习方面。这些技术正在被纳入认知诊断工具中，提高其精确度和有效性。皮尤研究中心进行的一项调查显示，55% 的美国人声称经常使用人工智慧，而 44% 的人认为他们不经常使用人工智慧。由于对个人化医疗的需求不断增长，欧洲成为第二大市场成长地区。

认知诊断市场-竞争格局：

认知诊断市场竞争非常激烈，许多竞争对手都在努力透过技术进步、策略联盟和产品独特性来获得市场份额。各组织正在投入大量资源进行研究和开发，以引入创新的诊断仪器和技术。这包括大脑成像、生物标记分析和人工智慧驱动的诊断系统的进展。企业正在透过进入新兴市场并在认知诊断需求不断增长的地区建立业务来扩大市场范围。这包括建立新设施、收购当地实体以及客製化产品以满足地区需求。公司透过创造独特的诊断仪器、提高精度、用户友好的介面以及与其他医疗保健技术的无缝整合而脱颖而出。这包括提供全面的诊断解决方案，解决认知评估的各个方面。

概述
- 透过诊断进行细分市场份额分析
- 脑部影像测试
  - 磁振造影 (MRI)
  - 电脑断层扫描 (CT)
  - 正子断层扫描 (PET) 和 PET/CT
- 实验室测试
  - 脑脊髓液（CSF）
  - 血液检查
- 心理状态测试
  - 简易精神状态检查 (MMSE)
  - 蒙特娄认知评估 (MoCA)
- 快速居家筛检测试
- 神经心理测试
- 脑电图（EEG）
- 认知功能和行为测试
- 神经精神问卷 (NPI-Q)

第 8 章：认知诊断市场 - 依适应症分类

概述
- 按指标分類的细分市场占有率分析
- 阿兹海默症
- 失智
- 其他神经系统疾病

第 9 章：认知诊断市场 - 按最终用户

概述
- 按最终用户分類的细分市场占有率分析
- 医院
- 神经内科诊所
- 復健中心
- 学术及研究机构
- 居家护理
- 其他的

第 10 章：认知诊断市场 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美认知诊断主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模及预测（按诊断）
- 北美市场规模和预测（按指标）
- 北美市场规模和预测（按最终用户）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲认知诊断主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模和预测（透过诊断）
- 欧洲市场规模与预测（按指标）
- 欧洲市场规模和预测（按最终用户）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区认知诊断主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模及预测（依诊断）
- 亚太地区市场规模与预测（依指标）
- 亚太地区市场规模和预测（按最终用户）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲认知诊断主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按诊断）
- 拉丁美洲市场规模与预测（按指标）
- 拉丁美洲市场规模和预测（按最终用户）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲认知诊断主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按诊断）
- 中东和非洲市场规模及预测（依指标）
- 中东和非洲市场规模和预测（按最终用户）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 认知诊断产业

竞争仪表板
公司简介
- Cognetivity Neurosciences
- Cognivue
- Cogstate
- Cambridge Cognition
- Diadem
- CN Diagnostics
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV3591

REPORT HIGHLIGHT

Cognitive Diagnostics Market size was valued at USD 5,390.21 million in 2023, expanding at a CAGR of 27.90% from 2024 to 2032.

Cognitive diagnostic models are a psychometric paradigm for designing and scoring tests to provide a profile of examinee skill mastery rather than just an overall test score. Cognitive diagnostics refers to the assessment and evaluation of cognitive functions, which include memory, attention, language, problem-solving, and other intellectual abilities. This field encompasses various techniques, tools, and technologies used to diagnose cognitive impairments and disorders, such as Alzheimer's disease, dementia, ADHD, and other neurological conditions. Cognitive diagnostics play a crucial role in the management and treatment of cognitive disorders, offering valuable insights into brain health and function. As technology advances, the field is expected to grow, providing more accurate, accessible, and affordable diagnostic options.

Cognitive Diagnostics Market- Market Dynamics

The growing geriatric population and increasing prevalence of cognitive disorders globally are expected to drive the growth of the market

The global demographic landscape is experiencing a swift aging trend, marked by a notable rise in the elderly population. This demographic shift places older adults at an elevated risk for cognitive impairments, including Alzheimer's disease and various forms of dementia. The World Health Organization projects that by the year 2030, one in six individuals worldwide will be aged 60 years or older. Consequently, the population segment aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion. Enhanced awareness and advancements in diagnostic methods are contributing to higher rates of identification for cognitive disorders. As diagnostic technologies evolve, more cases are being recognized and diagnosed at earlier stages-additionally, the ongoing technological innovations and the expansion of healthcare infrastructure present significant opportunities for market growth. Nevertheless, the absence of standardization may pose challenges to the market's expansion.

Cognitive Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 27.90% over the forecast period (2024-2032)

Based on region, North America was the leading revenue generator in 2023

Cognitive Diagnostics Market- Segmentation Analysis:

The Global Cognitive Diagnostics Market is segmented based on Diagnosis, Indication, End-User, and Region.

The market is segmented into eight distinct categories according to Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function & Behavioral Tests, and the Neuropsychiatric Inventory Questionnaire (NPI-Q). Each of these diagnostic categories is essential for delivering thorough evaluations and enhancing patient outcomes in the realm of cognitive health.

The market is segmented into two categories according to Indication: Alzheimer's disease, Dementia, and other neurological disorders. Each category includes distinct diagnostic tools and methods for evaluating and treating these conditions.

The market is segmented into two groups according to End-User: Hospitals, Neurology Clinics, Rehabilitation Centers, Academic and Research Institutes, Home Care, and Others. Each end-user group employs different diagnostic tools and techniques customized to their particular requirements and environments.

Cognitive Diagnostics Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries for business purposes. North America leads the market growth, driven by the increasing demand for diagnostic tools and technologies to assess cognitive performance. The region is a pioneer in technological advancements, especially in artificial intelligence (AI) and machine learning. These technologies are being incorporated into cognitive diagnostic tools, improving their precision and effectiveness. A survey conducted by Pew Research revealed that 55% of Americans claim to regularly use AI, while 44% believe they do not use it regularly. Europe follows as the second largest region for market growth, attributed to the rising demand for Personalized Medicine.

Cognitive Diagnostics Market- Competitive Landscape:

The cognitive diagnostics market is fiercely competitive, with a wide array of competitors striving to gain market share through technological advancements, strategic alliances, and product distinctiveness. Organizations are dedicating significant resources to research and development to introduce innovative diagnostic instruments and technologies. This encompasses progress in brain imaging, biomarker analysis, and AI-powered diagnostic systems. Businesses are broadening their market reach by venturing into emerging markets and establishing a presence in regions where there is a growing demand for cognitive diagnostics. This involves establishing new facilities, acquiring local entities, and customizing products to suit regional requirements. Companies set themselves apart by creating unique diagnostic instruments, enhancing precision, user-friendly interfaces, and seamless integration with other healthcare technologies. This includes providing comprehensive diagnostic solutions that address various aspects of cognitive evaluation.

Recent Developments:

C2N Diagnostics, a prominent entity in the field of advanced brain health diagnostics known for its PrecivityAD blood test, which assists in the diagnosis of Alzheimer's disease, has unveiled its latest innovative product. This new offering is expected to significantly improve care for individuals experiencing cognitive impairment: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA) designated for Research Use Only (RUO).

Cognetivity Neurosciences Ltd., a technology company specializing in brain health screening platforms for medical, commercial, and consumer settings, is excited to share that its leading CognICA tool has proven to be effective in monitoring cognitive function in Alzheimer's disease patients undergoing treatment with the disease-modifying therapy Aduhelm (aducanumab) from Biogen.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COGNITIVE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cognetivity Neurosciences
Cognivue
Cogstate
Cambridge Cognition
Diadem
CN Diagnostics
Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

Brain Imaging Tests
Magnetic Resonance Imaging (MRI)
Computerized Tomography (CT)
Positron Emission Tomography (PET) and PET/CT
Laboratory Testing
Cerebrospinal fluid (CSF)
Blood Tests
Mental Status Testing
Mini-Mental State Exam (MMSE)
Montreal Cognitive Assessment (MoCA)
Rapid Home Screening Tests
Neuropsychological Testing
Electroencephalogram (EEG)
Cognitive Function & Behavioral Tests
Neuropsychiatric Inventory Questionnaire (NPI-Q)
GLOBAL COGNITIVE DIAGNOSTICS MARKET, INDICATION BY - MARKET ANALYSIS, 2019 - 2032
Alzheimer's disease
Dementia
Others neurological disorders

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Neurology Clinics
Rehabilitation Centers
Academic and Research Institutes
Home Care
Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cognitive Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cognitive Diagnostics Market Snippet by Diagnosis
- 2.1.2. Cognitive Diagnostics Market Snippet by Indication
- 2.1.3. Cognitive Diagnostics Market Snippet by End-User
- 2.1.4. Cognitive Diagnostics Market Snippet by Country
- 2.1.5. Cognitive Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Cognitive Diagnostics Key Market Trends

3.1. Cognitive Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cognitive Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cognitive Diagnostics Market Opportunities
3.4. Cognitive Diagnostics Market Future Trends

4. Cognitive Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cognitive Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cognitive Diagnostics Market Landscape

6.1. Cognitive Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cognitive Diagnostics Market - By Diagnosis

7.1. Overview
- 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 7.1.2. Brain Imaging Tests
  - 7.1.2.1. Magnetic Resonance Imaging (MRI)
  - 7.1.2.2. Computerized Tomography (CT)
  - 7.1.2.3. Positron Emission Tomography (PET) and PET/CT
- 7.1.3. Laboratory Testing
  - 7.1.3.1. Cerebrospinal fluid (CSF)
  - 7.1.3.2. Blood Tests
- 7.1.4. Mental Status Testing
  - 7.1.4.1. Mini-Mental State Exam (MMSE)
  - 7.1.4.2. Montreal Cognitive Assessment (MoCA)
- 7.1.5. Rapid Home Screening Tests
- 7.1.6. Neuropsychological Testing
- 7.1.7. Electroencephalogram (EEG)
- 7.1.8. Cognitive Function & Behavioral Tests
- 7.1.9. Neuropsychiatric Inventory Questionnaire (NPI-Q)

8. Cognitive Diagnostics Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 8.1.2. Alzheimer's disease
- 8.1.3. Dementia
- 8.1.4. Others neurological disorders

9. Cognitive Diagnostics Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Neurology Clinics
- 9.1.4. Rehabilitation Centers
- 9.1.5. Academic and Research Institutes
- 9.1.6. Home Care
- 9.1.7. Others

10. Cognitive Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Cognitive Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cognitive Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cognitive Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cognitive Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cognitive Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cognitive Diagnostics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Cognetivity Neurosciences
- 11.2.2. Cognivue
- 11.2.3. Cogstate
- 11.2.4. Cambridge Cognition
- 11.2.5. Diadem
- 11.2.6. CN Diagnostics
- 11.2.7. Others